148 related articles for article (PubMed ID: 24675088)
1. An integrated characterization of serological, pathological, and functional events in doxorubicin-induced cardiotoxicity.
Cove-Smith L; Woodhouse N; Hargreaves A; Kirk J; Smith S; Price SA; Galvin M; Betts CJ; Brocklehurst S; Backen A; Radford J; Linton K; Roberts RA; Schmitt M; Dive C; Tugwood JD; Hockings PD; Mellor HR
Toxicol Sci; 2014 Jul; 140(1):3-15. PubMed ID: 24675088
[TBL] [Abstract][Full Text] [Related]
2. Identifying early stages of doxorubicin-induced cardiotoxicity in rat model by 7.0 tesla cardiovascular magnetic resonance combining hematological and pathological parameters.
Wang S; Zhu T; Wang C; Wang L; He B; Gao F
Magn Reson Imaging; 2022 Jul; 90():17-25. PubMed ID: 35122985
[TBL] [Abstract][Full Text] [Related]
3. Anthracycline Therapy Is Associated With Cardiomyocyte Atrophy and Preclinical Manifestations of Heart Disease.
Ferreira de Souza T; Quinaglia A C Silva T; Osorio Costa F; Shah R; Neilan TG; Velloso L; Nadruz W; Brenelli F; Sposito AC; Matos-Souza JR; Cendes F; Coelho OR; Jerosch-Herold M; Coelho-Filho OR
JACC Cardiovasc Imaging; 2018 Aug; 11(8):1045-1055. PubMed ID: 30092965
[TBL] [Abstract][Full Text] [Related]
4. Novel approach to early detection of doxorubicin cardiotoxicity by gadolinium-enhanced cardiovascular magnetic resonance imaging in an experimental model.
Lightfoot JC; D'Agostino RB; Hamilton CA; Jordan J; Torti FM; Kock ND; Jordan J; Workman S; Hundley WG
Circ Cardiovasc Imaging; 2010 Sep; 3(5):550-8. PubMed ID: 20622140
[TBL] [Abstract][Full Text] [Related]
5. Experimental determination of diagnostic window of cardiac troponins in the development of chronic anthracycline cardiotoxicity and estimation of its predictive value.
Adamcova M; Lencova-Popelova O; Jirkovsky E; Mazurova Y; Palicka V; Simko F; Gersl V; Sterba M
Int J Cardiol; 2015 Dec; 201():358-67. PubMed ID: 26310978
[TBL] [Abstract][Full Text] [Related]
6. Immune response proteins as predictive biomarkers of doxorubicin-induced cardiotoxicity in breast cancer patients.
Yu LR; Cao Z; Makhoul I; Daniels JR; Klimberg S; Wei JY; Bai JP; Li J; Lathrop JT; Beger RD; Todorova VK
Exp Biol Med (Maywood); 2018 Feb; 243(3):248-255. PubMed ID: 29224368
[TBL] [Abstract][Full Text] [Related]
7. Rat Model of Cardiotoxic Drug-Induced Cardiomyopathy.
Nakahara T; Tanimoto T; Petrov AD; Ishikawa K; Strauss HW; Narula J
Methods Mol Biol; 2018; 1816():221-232. PubMed ID: 29987823
[TBL] [Abstract][Full Text] [Related]
8. Liposomal doxorubicin attenuates cardiotoxicity via induction of interferon-related DNA damage resistance.
Gyöngyösi M; Lukovic D; Zlabinger K; Spannbauer A; Gugerell A; Pavo N; Traxler D; Pils D; Maurer G; Jakab A; Riesenhuber M; Pircher A; Winkler J; Bergler-Klein J
Cardiovasc Res; 2020 Apr; 116(5):970-982. PubMed ID: 31346605
[TBL] [Abstract][Full Text] [Related]
9. Cardiac MRI Myocardial Functional and Tissue Characterization Detects Early Cardiac Dysfunction in a Mouse Model of Chemotherapy-Induced Cardiotoxicity.
Naresh NK; Misener S; Zhang Z; Yang C; Ruh A; Bertolino N; Epstein FH; Collins JD; Markl M; Procissi D; Carr JC; Allen BA
NMR Biomed; 2020 Sep; 33(9):e4327. PubMed ID: 32567177
[TBL] [Abstract][Full Text] [Related]
10. Early Detection and Serial Monitoring of Anthracycline-Induced Cardiotoxicity Using T1-mapping Cardiac Magnetic Resonance Imaging: An Animal Study.
Hong YJ; Park HS; Park JK; Han K; Park CH; Kim TK; Yoo SJ; Lee JY; Kim PK; Hur J; Lee HJ; Kim YJ; Suh YJ; Paek MY; Choi BW
Sci Rep; 2017 Jun; 7(1):2663. PubMed ID: 28572614
[TBL] [Abstract][Full Text] [Related]
11. Short-term and long-term models of doxorubicin-induced cardiomyopathy in rats: A comparison of functional and histopathological changes.
O'Connell JL; Romano MM; Campos Pulici EC; Carvalho EE; de Souza FR; Tanaka DM; Maciel BC; Salgado HC; Fazan-Júnior R; Rossi MA; Simões MV
Exp Toxicol Pathol; 2017 Apr; 69(4):213-219. PubMed ID: 28153388
[TBL] [Abstract][Full Text] [Related]
12. High-sensitive cardiac troponin-I facilitates timely detection of subclinical anthracycline-mediated cardiac injury.
Jones M; O'Gorman P; Kelly C; Mahon N; Fitzgibbon MC
Ann Clin Biochem; 2017 Jan; 54(1):149-157. PubMed ID: 27170025
[TBL] [Abstract][Full Text] [Related]
13. Early decline in left ventricular ejection fraction predicts doxorubicin cardiotoxicity in lymphoma patients.
Nousiainen T; Jantunen E; Vanninen E; Hartikainen J
Br J Cancer; 2002 Jun; 86(11):1697-700. PubMed ID: 12087452
[TBL] [Abstract][Full Text] [Related]
14. Doxorubicin-Induced Myocardial Fibrosis Involves the Neurokinin-1 Receptor and Direct Effects on Cardiac Fibroblasts.
Levick SP; Soto-Pantoja DR; Bi J; Hundley WG; Widiapradja A; Manteufel EJ; Bradshaw TW; Meléndez GC
Heart Lung Circ; 2019 Oct; 28(10):1598-1605. PubMed ID: 30205930
[TBL] [Abstract][Full Text] [Related]
15. Remote ischaemic preconditioning ameliorates anthracycline-induced cardiotoxicity and preserves mitochondrial integrity.
Galán-Arriola C; Villena-Gutiérrez R; Higuero-Verdejo MI; Díaz-Rengifo IA; Pizarro G; López GJ; Molina-Iracheta A; Pérez-Martínez C; García RD; González-Calle D; Lobo M; Sánchez PL; Oliver E; Córdoba R; Fuster V; Sánchez-González J; Ibanez B
Cardiovasc Res; 2021 Mar; 117(4):1132-1143. PubMed ID: 32597960
[TBL] [Abstract][Full Text] [Related]
16. Doxorubicin-induced delayed-onset subclinical cardiotoxicity in mice.
Desai VG; Vijay V; Han T; Moland CL; Phanavanh B; Lee T; Davis KJ; Muskhelishvili L; Stine KC; Fuscoe JC
J Appl Toxicol; 2022 May; 42(5):778-792. PubMed ID: 34668590
[TBL] [Abstract][Full Text] [Related]
17. Early Administration of Carvedilol Protected against Doxorubicin-Induced Cardiomyopathy.
Chen YL; Chung SY; Chai HT; Chen CH; Liu CF; Chen YL; Huang TH; Zhen YY; Sung PH; Sun CK; Chua S; Lu HI; Lee FY; Sheu JJ; Yip HK
J Pharmacol Exp Ther; 2015 Dec; 355(3):516-27. PubMed ID: 26511374
[TBL] [Abstract][Full Text] [Related]
18. Plasma concentrations of NT-pro-BNP and cardiac troponin-I in relation to doxorubicin-induced cardiomyopathy and cardiac function in childhood malignancy.
Soker M; Kervancioglu M
Saudi Med J; 2005 Aug; 26(8):1197-202. PubMed ID: 16127512
[TBL] [Abstract][Full Text] [Related]
19. Ultrastructural and Echocardiographic Assessment of Chronic Doxorubicin-Induced Cardiotoxicity in Rats.
Babaei H; Razmaraii N; Assadnassab G; Mohajjel Nayebi A; Azarmi Y; Mohammadnejad D; Azami A
Arch Razi Inst; 2020 Mar; 75(1):55-62. PubMed ID: 32292003
[TBL] [Abstract][Full Text] [Related]
20. Neuregulin-1 attenuated doxorubicin-induced decrease in cardiac troponins.
Bian Y; Sun M; Silver M; Ho KK; Marchionni MA; Caggiano AO; Stone JR; Amende I; Hampton TG; Morgan JP; Yan X
Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H1974-83. PubMed ID: 19801490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
